Franklin Genomic Advancements Etf ETF Forecast

Buy or Hold candidate since May 27, 2026 Gain 13.18%

The Franklin Genomic Advancements ETF price fell by -1.57% on the last day (Friday, 31st Jul 2026) from $39.54 to $38.92. During the last trading day the ETF fluctuated 1.11% from a day low at $38.72 to a day high of $39.15. The price has been going up and down for this period, and there has been a -0.76% loss for the last 2 weeks. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -2 thousand shares and in total, 4 thousand shares were bought and sold for approximately $163.85 thousand.

Given the current short-term trend, the ETF is expected to rise 22.77% during the next 3 months and, with a 90% probability hold a price between $47.78 and $53.17 at the end of this 3-month period.

HELX Signals & Forecast

The Franklin Genomic Advancements ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $39.03. On a fall, the ETF will find some support from the long-term average at approximately $38.72. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -5.53%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this ETF may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Franklin Genomic Advancements ETF

Franklin Genomic Advancements finds support from accumulated volume at $38.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the ETF. During the last day, the ETF moved $0.431 between high and low, or 1.11%. For the last week the ETF has had daily average volatility of 1.18%.

Our recommended stop-loss: $37.12 (-4.62%) (This ETF has low daily movements and this gives low risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (HELX) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Franklin Genomic Advancements ETF to open at $38.93, and during the day (based on 14 day Average True Range), to move between $38.65 and $39.19, which gives a possible trading interval of +/-$0.544 (+/-1.41%) up or down from last closing price. If Franklin Genomic Advancements ETF takes out the full calculated possible swing range there will be an estimated 1.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $38.89 (0.07%) than the resistance at $39.54 (1.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Franklin Genomic Advancements ETF ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Franklin Genomic Advancements ETF to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.375 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $38.93 ( 0.0266%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk